New safety check for rare genetic disorder treatment
NCT ID NCT07219485
Summary
This study is checking the long-term safety of a medication called pitolisant for people with Prader-Willi syndrome, a rare genetic disorder. It's open to about 150 participants who have already taken pitolisant in previous related studies. Researchers will monitor participants every six months to track any side effects from continued use of the medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRADER-WILLI SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Science 37
Morrisville, North Carolina, 27560, United States
Conditions
Explore the condition pages connected to this study.